Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative timing of LMWH for DVT prophylaxis in orthopaedic surgery
ChiCTR2300076243Phase 4Recruiting
- Sponsor
- The First Affiliated Hospital of Wenzhou Medical University
- Start
- Aug 2022
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4, randomised, single-blind trial of low molecular weight heparin calcium in deep vein thrombosis (DVT) (4 arms), sponsored by The First Affiliated Hospital of Wenzhou Medical University. Primary endpoints: D-dimer and Lower extremity vascular ultrasound. Started Aug 2022; status: recruiting.
02
Drugs
low molecular weight heparin calcium
03
Conditions
deep vein thrombosis (DVT)
Beyond the preview
Go deeper on ChiCTR2300076243.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300076243.